Publications by authors named "Christina Ann Ortmann"
Future Oncol
November 2013
Article Synopsis
- - Platinum-based combination chemotherapy is effective for advanced bladder cancer, but most patients eventually experience disease progression, highlighting the need for better second-line treatments.
- - Vinflunine is the only chemotherapy agent showing survival benefits in clinical trials, but its response rates are disappointing and lack direct comparisons with other treatments like taxanes.
- - Recent developments in identifying prognostic factors and testing new biological agents aim to address chemoresistance, as reviewed in the latest findings from Phase II/III trials for managing advanced urothelial cancer.
